Can smarter epidural delivery ease labour pain better?
NCT ID NCT02278601
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial tests three ways of delivering epidural pain relief during labour in first-time mothers. The goal is to see which method best prevents breakthrough pain—when the epidural wears off and extra pain relief is needed. The study also looks at whether better pain control could reduce the need for assisted deliveries like forceps or Caesarean sections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Epidural delivery system using ropivacaine and fentanyl
- What this could lead to
- If successful, this could identify a better way to deliver epidural pain relief during labour, reducing breakthrough pain and potentially lowering the need for Caesarean or instrumental deliveries.
- What could go wrong
- The trial is large but results may vary among individuals. Epidural analgesia carries risks like low blood pressure or headache, and the best method may not prove superior for all outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAKTHROUGH PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
KK Women's and Children's Hospital
Singapore, 229899, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.